Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-25T01:51:55.901Z Has data issue: false hasContentIssue false

Ultrastructural Pathology of Neurofibrillary Tangles in Transgenic Mice Carrying Mutant (P301l) Human Tau Gene

Published online by Cambridge University Press:  02 July 2020

W.-L. Lin
Affiliation:
Mayo Clinic Jacksonville, Jacksonville, FL, 32224
J. Lewis
Affiliation:
Mayo Clinic Jacksonville, Jacksonville, FL, 32224
A.R. Corral
Affiliation:
Mayo Clinic Jacksonville, Jacksonville, FL, 32224
D.W. Dickson
Affiliation:
Mayo Clinic Jacksonville, Jacksonville, FL, 32224
M. Hutton
Affiliation:
Mayo Clinic Jacksonville, Jacksonville, FL, 32224
Get access

Extract

Tau is a microtubule-associated protein that promotes polymerization and stabilization of microtubules. It is the major component of fibrillary neuronal and glial inclusions in Alzheimer's disease (AD) and the tauopathies. An autosomal dominant familial tauopathy, frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), has been shown to be caused by pathogenic tau mutations. Neuropathologic features of FTDP-17 are filamentous tau aggregates in neurons and glia. Previous transgenic mice carrying the normal human tau gene developed motor neuron disease and had dystrophic axons, but no neurofibrillary tangles (NFT). In this report we describe ultrastructural features of NFT in transgenic mice carrying a mutant human tau gene. The mice were generated with a tau cDNA containing exon 1, 4, 5, 7, 9, 10, 11-13, intron 13 and exon 14, driven by the mouse prion promoter (MoPrP) and containing the most common FTDP-17 mutation, P301L. The transgenic construct was generated by ligating the P301L tau cDNA with the mouse prion promoter.

Type
Pathology
Copyright
Copyright © Microscopy Society of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References:

1.Hutton, M. et al., Nature 393(1998)702.CrossRefGoogle Scholar
2.Brion, J.-P. et al., Am J Pathol 154(1999)255.CrossRefGoogle Scholar
3.Ishihara, T. et al., Neuron 24(1999)751.CrossRefGoogle Scholar
4. Supported by NIH grant P01 AG 17216.Google Scholar